REN and Hypertension: Furthermore, the use of ACEIs and ARBs in China is relatively low; in 1 study, renin-angiotensin system inhibitors were reported to be used in 25% to 30% of treated patients.[30] These factors might be the reasons that hypertension was not a risk factor in our study.